Information Provided By: 
Fly News Breaks for January 30, 2018
TFX
Jan 30, 2018 | 07:09 EDT
Leerink analyst Richard Newitter raised his price target for Teleflex to $321 from $307 saying recent checks reinforce his view that the company can nearly double its organic sales growth profile by 2019 once Neotract/Urolift turns organic. With the step-up in growth that Neotract provides, the analyst believes Teleflex will be able to sustain 7%-8% top-line growth through 2020 while delivering 15%-20% EPS growth. Newitter reiterates an Outperform rating on the shares.
News For TFX From the Last 2 Days
There are no results for your query TFX
